EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors

Emre Eken iD, Emel Ayvaz Güneyin iD, Elif Büyükkurt iD, Faruk Yıldız iD, Mehmet Bilici iD, Canan Dinar Ayman iD

Current Oncology · 22.05.2026 · 33 (6) · 302

DOI: 10.3390/curroncol33060302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 22.05.2026. Verfasst von Emre Eken und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye. Hauptthemen laut MEDLINE: Melanoma, Neutrophils, Immune Checkpoint Inhibitors, Albumins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although immune checkpoint inhibitors (ICIs) have improved survival in advanced melanoma, predicting individual responses remains challenging; thus, practical and inexpensive biomarkers are needed. In this study, we investigated the prognostic value of the neutrophil percentage–albumin ratio (NPAR) in patients with advanced melanoma receiving ICI therapy.

Methods

Fifty patients treated in our clinic were included, with a mean age of 53.3 years and 66% being male. Visceral metastases were present in 76% of the cohort. Through conducting Receiver Operating Characteristic (ROC) analysis, we determined an NPAR cut-off value of 1.81, with patients categorized into low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNeutrophilsImmune Checkpoint InhibitorsAlbuminsHumansMaleMiddle AgedPrognosisFemaleAgedAdult

Stichwörter der Autor:innen

immunotherapymelanomaneutrophil percentage–albumin ratio

Substanzen

Immune Checkpoint InhibitorsAlbumins

Autor:innen und Institutionen

  • Department of Medical Oncology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye.
  • Department of Internal Medicine, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye.

ORCID-Profile: Emre Eken, Emel Ayvaz Güneyin, Elif Büyükkurt, Faruk Yıldız, Mehmet Bilici, Canan Dinar Ayman

Zitieren

APA

Eken, E., Güneyin, E. A., Büyükkurt, E., Yıldız, F., Bilici, M., & Ayman, C. D. (2026). Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology, 33(6), 302. https://doi.org/10.3390/curroncol33060302

Vancouver

Eken E, Güneyin EA, Büyükkurt E, Yıldız F, Bilici M, Ayman CD. Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology. 2026;33(6):302. doi:10.3390/curroncol33060302

BibTeX
@article{Eken2026,
  author = {Eken, Emre and Güneyin, Emel Ayvaz and Büyükkurt, Elif and Yıldız, Faruk and Bilici, Mehmet and Ayman, Canan Dinar},
  title = {Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {302},
  doi = {10.3390/curroncol33060302}
}
Kostenlos starten →